Xeris Pharmaceuticals Inc (XERS NASDAQ) stock market data APIs
$7.6864
-0.09(-1.2%)
as of September 17, 2025
Try our APIs with
free plan!
Xeris Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Prev. Close
7.6864
Open
7.5919
High
7.813
Low
7.4344
52 wk Range
2.69-8.03
Market Cap
1 239 M
Shares Outstanding
161 M
Revenue
246 M
EPS
-0.01
Beta
0.912
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Xeris Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Xeris Pharmaceuticals Inc data using free add-ons & libraries
Get Xeris Pharmaceuticals Inc Fundamental Data
Xeris Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 246 M
- EBITDA: 8 381 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-07
- EPS/Forecast: -0.03
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Xeris Pharmaceuticals Inc News
New
Xeris Biopharma Holdings, Inc. (XERS) Reports Record $71.5M Q2 Revenue
We recently published 10 Best Biotech Stocks to Buy Under $10. Xeris Biopharma Holdings, Inc. is placed among them. Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) is a Chicago-based commercial-stage bi...
H.C. Wainwright assumes coverage on Xeris Pharmaceuticals stock with Buy rating
Investing.com - H.C. Wainwright has assumed coverage on Xeris Pharmaceuticals (NASDAQ:XERS), currently trading at $7.20 with a market capitalization of $1.16 billion, with a Buy rating and a $10.00 ...
Xeris raises 2025 revenue guidance to $280M–$290M following 49% Q2 growth, led by Recorlev
Earnings Call Insights: Xeris Biopharma Holdings, Inc. (XERS) Q2 2025 MANAGEMENT VIEW * John P. Shannon, CEO, reported "the strong momentum we established in the first quarter continued into the s...
Traders are paying attention to the gapping stocks in Thursday's session.
Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps. [gap] TOP GAP UP STOCKS TICKER CHANGE COMMENT AVAH [...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
